Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers

Aromatase inhibitors are used to treat oestrogen-receptor-positive breast cancer. Here, the authors use genomic approaches to analyse tumours before and after neo-adjuvant treatment and find that treatment alters the clonal landscape of the tumours.

Saved in:

Bibliographic Details
Main Authors:	Christopher A. Miller, Yevgeniy Gindin, Charles Lu, Obi L Griffith, Malachi Griffith, Dong Shen, Jeremy Hoog, Tiandao Li, David E. Larson, Mark Watson, Sherri R Davies, Kelly Hunt, Vera J. Suman, Jacqueline Snider, Thomas Walsh, Graham A. Colditz, Katherine DeSchryver, Richard K. Wilson, Elaine R. Mardis, Matthew J. Ellis
Format:	article
Language:	EN
Published:	Nature Portfolio 2016
Subjects:	Science Q
Online Access:	https://doaj.org/article/a6ce0b4a6c5a4496be23087aef9be2f5
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers

Similar Items